Nature, Published online: 10 July 2024; doi:10.1038/s41586-024-07627-2
Insufficient AHR activation has been suggested in SLE, and augmenting AHR activation therapeutically may prevent CXCL13+ TPH/TFH differentiation and the subsequent recruitment of B cells and formation of lymphoid aggregates in inflamed tissues.
Source link